Our results showed that IL-6, IL-7, IL-10, and IL-17A levels were elevated in the plasma supernatants of NSCLC patients as compared to those in healthy controls but were significantly lower than those in the tumor tissue supernatant; this finding suggests an increased inflammatory response in the TME. Here, IL6 is linked to non-small cell lung carcinoma.